Article
Decreased CD177pos neutrophils in myeloid neoplasms is associated with NPM1, RUNX1, TET2, and U2AF1 S34F mutations.
Leukemia research - 1 Jan 2022
Alayed Khaled, Meyerson Howard J
Abstract excerpt
A decreased percentage of CD177pos neutrophils is frequently present in MDS and AML and is a useful flow cytometry (FCM) marker for the identification of MDS. The underlying mechanism leading to the low percentage of CD177pos neutrophils in MDS has not been explained. The aim of this study was to identify whether specific somatic mutations in myeloid neoplasms are associated with the low percentage of CD177pos...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
